| Financial Year |
March 31 2023 |
| Monetary Funds |
1,819,141,876.89 |
| Held-for-trading Financial Assets |
14,193,123.42 |
| Notes Receivable |
-- |
| Accounts Receivable |
1,298,680,574.98 |
| Advances to Suppliers |
58,407,510.67 |
| Other Receivables |
22,381,053.54 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,310,055,392.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,726,120.24 |
| Total Current Assets |
4,620,643,473.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
468,791,952.66 |
| Investment Properties |
15,854,795.73 |
| Fixed Assetes |
79,658,483.79 |
| Under-construction Projects |
210,907,415.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
3,403,944.13 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,629,125.29 |
| Deferred Income Tax Assets |
28,021,413.03 |
| Other Non-Current Assets |
4,826,355.67 |
| Sub-Total of Non-Current Assets |
879,179,198.90 |
| Total Assets |
5,499,822,672.21 |
| Short-Term Loans |
297,512,861.13 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
190,767,295.98 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
424,448,551.01 |
| Taxes Payable |
102,728,267.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
99,502,670.02 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,477,870.52 |
| Other Current Liabilities |
159,873.67 |
| Sub-Total of Current Liabilities |
1,607,885,951.97 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
172,937.80 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
5,644,056.47 |
| Total Liabilities |
1,613,530,008.44 |
| Paid-In Capital(Or Share Stock) |
710,677,844.00 |
| Capital Surplus |
1,757,182,109.36 |
| Surplus Reserve |
180,194,001.54 |
| LESS:Treasury Stock |
234,393,496.80 |
| Undistributed Profits |
1,479,727,267.10 |
| Minority Stockholder's Interest |
11,838,623.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,874,454,040.04 |
| Owner's Equity（Stockholder's Equity） |
3,886,292,663.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,499,822,672.21 |
